CUBE vs NRIX
CubeSmart (CUBE) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the CUBE and NRIX stock pages for the full models.
Not investment advice.